Comprehensive prevention and treatment of nautical motion sickness from perspective of precise prevention for chemotherapy induced nausea and vomiting
-
摘要:
航海晕动病是一种常见的航海疾病，也是晕动症的重要亚型。随着民用航海与海军国防事业的发展，航海活动不断从近海向远海迈进，长远航任务日趋频繁，航海晕动病的发生越来越多，严重影响航海人员的工作效率。化疗所致恶心呕吐(CINV)是肿瘤化疗时代最常见的不良反应，与航海晕动病有着相似的临床表现(例如恶性、呕吐、头晕等)。随着对CINV认识的不断加深，通过精准预测、精准用药、联合策略等防治机制, CINV的发生率得到有效控制。本研究从CINV精准防控角度出发，分析精准预测以及综合防治航海晕动病的策略，促使航海人员更好地适应远航任务，也为航海晕动病的研究提供新的方向。
Abstract:Nautical motion sickness is a common nautical disease and an important subtype of motion sickness. With the development of civil navigation and navy national defense, navigation activities are constantly moving from offshore to outer ocean area, and the increasingly frequent long-distance navigation tasks lead to more frequently occurrence of motion sickness, which seriously affects the working efficiency of seafarers. With the deepening understanding of CINV, the incidence of CINV has been effectively controlled through prevention and control mechanisms such as accurate prediction, precise medication and joint strategies. From the perspective of precise prevention and control for CINV, this study analyzed the strategies of precise prediction and comprehensive prevention and control for nautical motion sickness, so as to enable seafarers to better adapt to long-distance missions, and also provide a new direction for the study of nautical motion sickness.
-
-
[1] LEUNG A K, HON K L. Motion sickness: an overview[J]. Drugs Context, 2019, 8: 19-34.
[2] GUPTA K, WALTON R, KATARIA S P. Chemotherapy-induced nausea and vomiting: pathogenesis, recommendations, and new trends[J]. Cancer Treat Res Commun, 2021, 26: 100278. doi: 10.1016/j.ctarc.2020.100278
[3] AAPRO M, ZHANG L, YENNU S, et al. Preventing chemotherapy-induced nausea and vomiting with netupitant/palonosetron, the first fixed combination antiemetic: current and future perspective[J]. Future Oncol, 2019, 15(10): 1067-1084. doi: 10.2217/fon-2018-0872
[4] AAPRO M, NAVARI R M, ROELAND E, et al. Efficacy of intravenous NEPA, a fixed NK1/5-HT3 receptor antagonist combination, for the prevention of chemotherapy-induced nausea and vomiting (CINV) during cisplatin-and anthracycline cyclophosphamide (AC)-based chemotherapy: a review of phase 3 studies[J]. Crit Rev Oncol Hematol, 2021, 157: 103143. doi: 10.1016/j.critrevonc.2020.103143
[5] LYONS E, LINE C, LEE J J. Developing drugs for prevention of chemotherapy-induced nausea and vomiting: draft guidance from the FDA[J]. Clin Cancer Res, 2021, 27(22): 6072-6074. doi: 10.1158/1078-0432.CCR-21-1941
[6] 潘磊磊, 祁瑞瑞, 王俊骎, 等. 晕动病前庭生理机制研究进展[J]. 第二军医大学学报, 2016, 37(8): 1012-1018. doi: 10.16781/j.0258-879x.2016.08.1012 [7] 朱琳, 张景翔, 邢信昊, 等. 晕动病发病机制研究进展[J]. 中华航海医学与高气压医学杂志, 2021, 28(4): 531-533. doi: 10.3760/cma.j.cn31184720210206-00051 [8] MITTELSTAEDT J M. Individual predictors of the susceptibility for motion-related sickness: a systematic review[J]. J Vestib Res, 2020, 30(3): 165-193. doi: 10.3233/VES-200702
[9] KOSLUCHER F, HAALAND E, MALSCH A, et al. Sex differences in the incidence of motion sickness induced by linear visual oscillation[J]. Aerosp Med Hum Perform, 2015, 86(9): 787-793. doi: 10.3357/AMHP.4243.2015
[10] MATCHOCK R L, LEVINE M E, GIANAROS P J, et al. Susceptibility to nausea and motion sickness as a function of the menstrual cycle[J]. Womens Health Issues, 2008, 18(4): 328-335. doi: 10.1016/j.whi.2008.01.006
[11] 姜淑芳, 孟昭刚, 单守勤. 我国晕船病的调查和防治研究进展[J]. 海军医学杂志, 2020, 41(2): 235-238. https://www.cnki.com.cn/Article/CJFDTOTAL-HJYX202002038.htm [12] 李进让, 朱荔, 袁伟, 等. 长远航环境下成人晕船习服适应能力的研究[J]. 中华耳鼻咽喉头颈外科杂志, 2012, 47(8): 642-645. doi: 10.3760/cma.j.issn.1673-0860.2012.08.007 [13] 韦林山, 周增桓, 潘奇波. 舰员上舰时间与晕船程度、生活质量的关系研究[J]. 中华航海医学与高气压医学杂志, 2011, 18(4): 229-231. doi: 10.3760/cma.j.issn.1009-6906.2011.04.014 [14] 朱荔, 李进让, 袁伟, 等. 多次长远航非舰员晕船脱适应现象分析[J]. 海军医学杂志, 2014, 35(3): 235-236. doi: 10.3969/j.issn.1009-0754.2014.03.030 [15] 王颖, 陈淑琴. 文职护士初次航海训练晕船的原因分析[J]. 解放军护理杂志, 2008, 25(11): 27-28. doi: 10.3969/j.issn.1008-9993.2008.11.012 [16] 莫烽锋, 郑国银, 吴良能, 等. 145名远洋航海人员中医体质类型与晕动病关系探讨[J]. 中西医结合学报, 2011, 9(4): 390-394. https://www.cnki.com.cn/Article/CJFDTOTAL-XBZX201104009.htm [17] 郝峻. 从中医"卫气"浅谈航海晕动病的治疗思路与方法[J]. 解放军医药杂志, 2019, 31(11): 109-112. doi: 10.3969/j.issn.2095-140X.2019.11.026 [18] 王金萍, 李海燕, 黄菲菲. 远航期间任务人员晕船病发生率与年龄的相关性[J]. 解放军医院管理杂志, 2021, 28(8): 703-705. https://www.cnki.com.cn/Article/CJFDTOTAL-JFYG202108003.htm [19] 刘锴, 李理, 姜庆军, 等. 乘员位置与晕船病发病率的相关性研究[J]. 实用医药杂志, 2013, 30(10): 921-924. doi: 10.3969/j.issn.1671-4008.2013.10.038 [20] 杨月珍, 包瀛春, 黄矛, 等. 综合训练法预防晕船病效果评估[J]. 解放军预防医学杂志, 2006, 24(3): 179-182. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYX200603007.htm [21] 刘民航, 郭俊生, 蔡建明, 等. 某陆军部队海上抗晕船适应性锻炼研究[J]. 解放军预防医学杂志, 2004, 22(2): 93-96. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYX200402005.htm [22] NUNES C P, RODRIGUES C C, CARDOSO C A F, et al. Clinical evaluation of the use of ginger extract in the preventive management of motion sickness[J]. Curr Ther Res Clin Exp, 2020, 92: 100591.
[23] ZHAO Q, NING B F, ZHOU J Y, et al. Transcutaneous electrical acustimulation ameliorates motion sickness induced by rotary chair in healthy subjects: a prospective randomized crossover study[J]. Neuromodulation, 2021(21): 06174-06182.
[24] 赵河通, 汤晓冬, 金韬骏, 等. 刮痧配合隔姜灸治疗航海运动病34例疗效观察[J]. 中华航海医学与高气压医学杂志, 2019, 26(5): 471-472. [25] 侯建萍, 林文珍, 黄继华, 等. 心理干预对晕船发生率的影响[J]. 西南国防医药, 2006, 16(6): 615-616. https://www.cnki.com.cn/Article/CJFDTOTAL-XNGF200606014.htm [26] STANKOVIC A S, ALVARENGA D L, COLEMAN DANIELS V R, et al. Intranasal scopolamine for motion sickness[J]. Aerosp Med Hum Perform, 2019, 90(11): 917-924.
[27] KESHAVARZ B, GOLDING J F. Motion sickness: current concepts and management[J]. Curr Opin Neurol, 2022, 35(1): 107-112.
[28] 段博, 姜树军, 徐洪涛. 航海运动病防治研究进展[J]. 中国研究型医院, 2017, 4(1): 42-46. https://www.cnki.com.cn/Article/CJFDTOTAL-YJXU201701018.htm
计量
- 文章访问数: 183
- HTML全文浏览量: 82
- PDF下载量: 14
下载:
苏公网安备 32100302010246号